The Past, Present, and Future of Biotech and Longevity with Laura Deming and Will Eden

Joining Erik on this episode are Laura Deming (@laurademing), creator of Longevity Fund, and Will Eden (@williamaeden), entrepreneur in residence with Errik Anderson at Ulysses and formerly of Thiel Capital. They talk about:- The history of biotech and the big trends and companies in the space over the past several decades.- The breakdown of the different areas within biotech.- The new business model in biotech that’s been driven by VCs.- How the public market in biotech companies is impacting the private market- The history of the FDA and how it has evolved over time, including the fact that in the beginning, the FDA only looked at whether a drug was safe, not whether it was effective.- How they would change the regulatory environment if they could wave a magic wand.- Why Laura says that the most effective individuals in biotech have a determinate worldview.- How longevity has emerged over the past several years, and the future of work in the space.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal.Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Grace Chen is our audio engineer and the show is produced by Brett Bolkowy.

There are no comments yet.

Please log in to write the first comment.